Signaturefd LLC increased its position in shares of DuPont Co. (NYSE:DD) by 30.4% during the second quarter, Holdings Channel reports. The fund owned 2,973 shares of the company’s stock after buying an additional 693 shares during the period. Signaturefd LLC’s holdings in DuPont were worth $193,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in DD. Integrated Investment Consultants LLC increased its stake in DuPont by 10.3% in the second quarter. Integrated Investment Consultants LLC now owns 2,050 shares of the company’s stock valued at $133,000 after buying an additional 191 shares in the last quarter. CrestPoint Capital Management LLC acquired a new stake in DuPont during the second quarter valued at about $201,000. Ariel Capital Advisors LLC acquired a new stake in DuPont during the second quarter valued at about $201,000. Nicolet Bankshares Inc. acquired a new stake in DuPont during the second quarter valued at about $209,000. Finally, Rockland Trust Co. acquired a new stake in DuPont during the second quarter valued at about $218,000. Hedge funds and other institutional investors own 70.29% of the company’s stock.
DuPont Co. (NYSE:DD) traded up 1.48% during trading on Friday, hitting $69.15. 1,375,425 shares of the stock traded hands. The stock has a market cap of $60.46 billion, a PE ratio of 27.51 and a beta of 1.78. DuPont Co. has a one year low of $50.71 and a one year high of $75.72. The company has a 50-day moving average price of $68.24 and a 200 day moving average price of $66.82.
DuPont (NYSE:DD) last issued its quarterly earnings data on Tuesday, July 26th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.14. The company earned $7.10 billion during the quarter, compared to analysts’ expectations of $7.01 billion. DuPont had a return on equity of 24.59% and a net margin of 9.01%. The business’s revenue was down .8% on a year-over-year basis. During the same period last year, the business earned $1.18 earnings per share. Analysts expect that DuPont Co. will post $3.19 earnings per share for the current year.
Several equities research analysts have issued reports on the stock. Barclays PLC boosted their price objective on shares of DuPont from $67.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 27th. Macquarie set a $71.00 price objective on shares of DuPont and gave the stock a “neutral” rating in a research note on Thursday, July 21st. TheStreet downgraded shares of DuPont from a “buy” rating to a “hold” rating in a research note on Tuesday, July 26th. Vetr cut shares of DuPont from a “sell” rating to a “strong sell” rating and set a $61.16 target price on the stock. in a research report on Monday, July 25th. Finally, Zacks Investment Research cut shares of DuPont from a “buy” rating to a “hold” rating in a research report on Tuesday, June 28th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have given a buy rating to the stock. DuPont presently has an average rating of “Hold” and an average target price of $70.73.
In other DuPont news, EVP Christopher Marc Doyle sold 5,422 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $69.53, for a total value of $376,991.66. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider James C. Jr. Collins sold 50,316 shares of the business’s stock in a transaction that occurred on Wednesday, August 24th. The shares were sold at an average price of $70.30, for a total value of $3,537,214.80. The disclosure for this sale can be found here. 0.31% of the stock is owned by corporate insiders.
E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company consists of over 10 businesses aggregated into six segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Its products include corn hybrids and soybean varieties, herbicides, fungicides and insecticides in Agriculture segment; photopolymers and electronic materials in Electronics & Communications segment; enzymes and bio-based materials in Industrial Biosciences segment; cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients in Nutrition & Health segment; engineering polymers, packaging and industrial polymers, films and elastomers in Performance Materials segment, and nonwovens, aramids and solid surfaces in Safety & Protection segment.
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont Co. (NYSE:DD).
Receive News & Ratings for DuPont Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont Co. and related companies with MarketBeat.com's FREE daily email newsletter.